Find Fluticasone Propionate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 80474-14-2, Flovent, Cutivate, Flixotide, Flonase, Flixonase
Molecular Formula
C25H31F3O5S
Molecular Weight
500.6  g/mol
InChI Key
WMWTYOKRWGGJOA-CENSZEJFSA-N
FDA UNII
O2GMZ0LF5W

Fluticasone Propionate
A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.
1 2D Structure

Fluticasone Propionate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
2.1.2 InChI
InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1
2.1.3 InChI Key
WMWTYOKRWGGJOA-CENSZEJFSA-N
2.1.4 Canonical SMILES
CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF
2.1.5 Isomeric SMILES
CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF
2.2 Other Identifiers
2.2.1 UNII
O2GMZ0LF5W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cutivate

2. Flixonase

3. Flixotide

4. Flonase

5. Flovent

6. Flovent Hfa

7. Fluticasone

8. Hfa, Flovent

9. Propionate, Fluticasone

2.3.2 Depositor-Supplied Synonyms

1. 80474-14-2

2. Flovent

3. Cutivate

4. Flixotide

5. Flonase

6. Flixonase

7. Flovent Hfa

8. Flunase

9. Flusonal

10. Fluspiral

11. Flutide

12. Flutivate

13. Asmatil

14. Axotide

15. Brethal

16. Fluinol

17. Flovent Diskus 50

18. Flixotide Disks

19. Flixotide Disk

20. Flovent Diskus

21. Flovent Diskus 100

22. Flovent Diskus 250

23. Flixotide Inhaler

24. Cultivate

25. Flixonase Nasal Spray

26. Fluticasonpropionat Allen

27. Cci-18781

28. Xhance

29. Fluticasone (propionate)

30. Cci 18781

31. Armonair Respiclick

32. Fluticasone-17-propionate

33. O2gmz0lf5w

34. Atemur

35. Chebi:31441

36. Nsc-759889

37. Inalacor

38. Rinosone

39. Trialona

40. Ubizol

41. Zoflut

42. Fluticasone Propionate (flonase, Veramyst)

43. Mfcd00866007

44. Flonase Aq

45. Pf-00241939

46. [(6s,8s,9r,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] Propanoate

47. Flovent-hfa

48. Fluticasone Propionate [usan]

49. Unii-o2gmz0lf5w

50. Fluxonal

51. Skyron

52. Flovent Rotadisk

53. Cutivate (tn)

54. Fluticasone Propionate [usan:usp]

55. Flonase (tn)

56. Flovent (tn)

57. Fluticasone-propionate

58. Armonair Respiclicktm

59. Flonase Allergy Relief

60. Fluticasone Impurity B

61. Prestwick0_000997

62. Prestwick1_000997

63. Prestwick2_000997

64. Prestwick3_000997

65. Cci18781

66. Schembl4068

67. Chembl1473

68. Bspbio_001093

69. Mls001424085

70. S-(fluoromethyl) 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate, 17-propionate

71. Fluticasone Propionate- Bio-x

72. Spbio_002984

73. Bpbio1_001203

74. Gtpl7080

75. Dtxsid8045511

76. Fluticasone Propionate (jan/usp)

77. Fn-25

78. Hms1571g15

79. Hms2051n19

80. Hms2098g15

81. Hms3413a19

82. Hms3677a19

83. Hms3715g15

84. Fluticasone Propionate [mi]

85. Amy38235

86. Hy-b0154

87. Ymb56612

88. Zinc3920027

89. Fluticasone Propionate [jan]

90. Ac-457

91. Bdbm50354849

92. S1992

93. Fluticasone Propionate [vandf]

94. Akos015895220

95. Fluticasone Propionate [mart.]

96. Ccg-100981

97. Cci-187881

98. Cs-1986

99. Db00588

100. Fluticasone Propionate [usp-rs]

101. Fluticasone Propionate [who-dd]

102. Ks-1173

103. Nc00231

104. Nsc 759889

105. Ncgc00179308-01

106. Ncgc00179308-05

107. Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6alpha,11beta,16alpha,17alpha)-s-(fluoromethyl) Ester

108. Bf160362

109. Bf161262

110. Smr000469159

111. Fluticasone Propionate [orange Book]

112. Ab00513992

113. Fluticasone Propionate [ep Monograph]

114. Advair Component Fluticasone Propionate

115. Fluticasone Propionate [usp Monograph]

116. A51110

117. D01708

118. Dymista Component Fluticasone Propionate

119. Ab00513992-06

120. Ab00513992_08

121. Fluticasone Propionate - Micronised Pharma Grade

122. Fluticasone Propionate Component Of Advair

123. Fluticasone Propionate, >=98% (hplc), Powder

124. 474f142

125. Advair Hfa Component Fluticasone Propionate

126. An-584/43505443

127. Fluticasone Propionate 100 Microg/ml In Methanol

128. Fluticasone Propionate Component Of Dymista

129. Lipo-102 Component Fluticasone Propionate

130. Sr-01000763355

131. Q-101393

132. Q8564098

133. Sr-01000763355-3

134. Brd-k62310379-001-03-0

135. Fluticasone Propionate 100 Microg/ml In Acetonitrile

136. Fluticasone Propionate Component Of Advair Hfa

137. Airduo Respiclick Component Fluticasone Propionate

138. Fluticasone 17(2)-carbonylsulfenic Acid 17-propionate

139. Fluticasone Propionate Component Of Airduo Respiclick

140. Fluticasone Propionate, European Pharmacopoeia (ep) Reference Standard

141. Fluticasone Propionate, United States Pharmacopeia (usp) Reference Standard

142. Fluticasone Propionate, Pharmaceutical Secondary Standard; Certified Reference Material

143. (1r,2s,8s,10s,11s,13r,14r,15s,17s)-1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl Propanoate

144. (6?,11?,16?,17?)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid Fluoromethyl Ester

145. 6alpha,9-difluoro-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-11beta-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17alpha-yl Propanoate

146. Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-s-(fluoromethyl) Ester

147. Androsta-1,4-diene-17-carbothioic Acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-,s-(fluoromethyl) Ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-

148. Fluticasone Propionate For Impurity C Identification, Europepharmacopoeia (ep) Reference Standard

149. Fluticasone Propionate For Impurity G Identification, Europepharmacopoeia (ep) Reference Standard

150. S-fluoromethyl 6.alpha., 9.alpha.-difluoro-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-17.alpha.-propionyloxyandrosta-1,4-diene-17.beta-. Carbothioate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 500.6 g/mol
Molecular Formula C25H31F3O5S
XLogP34
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count6
Exact Mass500.18442974 g/mol
Monoisotopic Mass500.18442974 g/mol
Topological Polar Surface Area106 Ų
Heavy Atom Count34
Formal Charge0
Complexity984
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 14  
Drug NameCutivate
PubMed HealthFluticasone
Drug ClassesAnti-Inflammatory, Corticosteroid, Intermediate, Corticosteroid, Strong
Drug LabelCUTIVATE (fluticasone propionate cream) Cream, 0.05% contains fluticasone propionate [(6,11,16,17)-6,9,-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid, S-fluoromethyl ester], a synthetic fluorina...
Active IngredientFluticasone propionate
Dosage FormLotion; Ointment
RouteTopical
Strength0.05%; 0.005%
Market StatusPrescription
CompanyFougera Pharms

2 of 14  
Drug NameFlonase
Drug LabelThe active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalation Aerosol, and FLOVENT HFA 220 mcg Inhalation Aerosol is fluticasone propionate, a corticosteroid having the chemical name S-(fluoromethyl) 6,9-difluoro-11...
Active IngredientFluticasone propionate
Dosage FormSpray, metered
RouteNasal
Strength0.05mg/spray
Market StatusPrescription
CompanyGlaxosmithkline

3 of 14  
Drug NameFlovent diskus 100
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.1mg/inh
Market StatusPrescription
CompanyGlaxo Grp

4 of 14  
Drug NameFlovent diskus 250
Drug LabelFluticasone propionate, the active component of Fluticasone Propionate Nasal Spray USP, is a synthetic corticosteroid having the chemical name S-(fluoromethyl)6,9-difluoro-11-17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carbothioate, 17-...
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.25mg/inh
Market StatusPrescription
CompanyGlaxo Grp

5 of 14  
Drug NameFlovent diskus 50
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.05mg/inh
Market StatusPrescription
CompanyGlaxo Grp

6 of 14  
Drug NameFlovent hfa
Active IngredientFluticasone propionate
Dosage FormAerosol, metered
RouteInhalation
Strength0.22mg/inh; 0.11mg/inh; 0.044mg/inh
Market StatusPrescription
CompanyGlaxo Grp

7 of 14  
Drug NameFluticasone propionate
Drug LabelFluticasone propionate, the active component of FLONASE Nasal Spray, is a synthetic corticosteroid having the chemical name S-(fluoromethyl)6,9-difluoro-11-17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carbothioate, 17-propionate and the...
Active IngredientFluticasone propionate
Dosage FormOintment; Spray, metered; Cream; Lotion
RouteNasal; Topical
Strength0.05%; 0.005%; 0.05mg/spray
Market StatusPrescription
CompanyWockhardt; Apotex; Roxane; Glenmark Generics; Fougera Pharms; Hi Tech Pharma; Perrigo New York; Tolmar; G And W Labs; Perrigo Israel

8 of 14  
Drug NameFlovent diskus 250
Drug LabelFluticasone propionate, the active component of Fluticasone Propionate Nasal Spray USP, is a synthetic corticosteroid having the chemical name S-(fluoromethyl)6,9-difluoro-11-17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carbothioate, 17-...
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.25mg/inh
Market StatusPrescription
CompanyGlaxo Grp

9 of 14  
Drug NameFlovent diskus 50
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.05mg/inh
Market StatusPrescription
CompanyGlaxo Grp

10 of 14  
Drug NameFlovent hfa
Active IngredientFluticasone propionate
Dosage FormAerosol, metered
RouteInhalation
Strength0.22mg/inh; 0.11mg/inh; 0.044mg/inh
Market StatusPrescription
CompanyGlaxo Grp

11 of 14  
Drug NameFluticasone propionate
Drug LabelFluticasone propionate, the active component of FLONASE Nasal Spray, is a synthetic corticosteroid having the chemical name S-(fluoromethyl)6,9-difluoro-11-17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carbothioate, 17-propionate and the...
Active IngredientFluticasone propionate
Dosage FormOintment; Spray, metered; Cream; Lotion
RouteNasal; Topical
Strength0.05%; 0.005%; 0.05mg/spray
Market StatusPrescription
CompanyWockhardt; Apotex; Roxane; Glenmark Generics; Fougera Pharms; Hi Tech Pharma; Perrigo New York; Tolmar; G And W Labs; Perrigo Israel

12 of 14  
Drug NameCutivate
PubMed HealthFluticasone
Drug ClassesAnti-Inflammatory, Corticosteroid, Intermediate, Corticosteroid, Strong
Drug LabelCUTIVATE (fluticasone propionate cream) Cream, 0.05% contains fluticasone propionate [(6,11,16,17)-6,9,-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid, S-fluoromethyl ester], a synthetic fluorina...
Active IngredientFluticasone propionate
Dosage FormLotion; Ointment
RouteTopical
Strength0.05%; 0.005%
Market StatusPrescription
CompanyFougera Pharms

13 of 14  
Drug NameFlonase
Drug LabelThe active component of FLOVENT HFA 44 mcg Inhalation Aerosol, FLOVENT HFA 110 mcg Inhalation Aerosol, and FLOVENT HFA 220 mcg Inhalation Aerosol is fluticasone propionate, a corticosteroid having the chemical name S-(fluoromethyl) 6,9-difluoro-11...
Active IngredientFluticasone propionate
Dosage FormSpray, metered
RouteNasal
Strength0.05mg/spray
Market StatusPrescription
CompanyGlaxosmithkline

14 of 14  
Drug NameFlovent diskus 100
Active IngredientFluticasone propionate
Dosage FormPowder
RouteInhalation
Strength0.1mg/inh
Market StatusPrescription
CompanyGlaxo Grp

4.2 Drug Indication

Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.


FDA Label


Treatment of asthma


5 Pharmacology and Biochemistry
5.1 Pharmacology

Systemically, fluticasone propionate activates glucocorticoid receptors, and inhibits lung eosinophilia in rats. Fluticasone propionate as a topical formulation is also associated with vasoconstriction in the skin.


5.2 MeSH Pharmacological Classification

Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


Bronchodilator Agents

Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)


Dermatologic Agents

Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]
5.4 Absorption, Distribution and Excretion

Absorption

Intranasal bioavailability of fluticasone propionate is <2%, and oral bioavailability is <1%. Intranasal exposure results in the majority of the dose being swallowed. Topical absorption of fluticasone propionate is very low but can change depending on a number of factors including integrity of the skin and the presence of inflammation or disease. A study of 24 healthy Caucasian males showed an inhaled bioavailability of 9.0%.


Route of Elimination

Fluticasone propionate is mainly eliminated in the feces with <5% eliminated in the urine.


Volume of Distribution

The volume of distribution of intravenous fluticasone propionate is 4.2L/kg. A study of 24 healthy Caucasian males showed a volume of distribution at steady state of 577L following intravenous administration.


Clearance

1093mL/min for fluticasone propionate. A study of 24 healthy Caucasian males showed a clearance of 63.9L/h following intravenous administration.


5.5 Metabolism/Metabolites

Fluticasone propionate is cleared from hepatic metabolism by cytochrome P450 3A4. Fluticasone propionate is hydrolysed at the FIVE-S-fluoromethyl carbothioate group, forming an inactive metabolite.


5.6 Biological Half-Life

7.8 hours for intravenous fluticasone propionate. A study of 24 healthy Caucasian males shows a half life of 14.0 hours following intravenous administration and 10.8 hours following inhalation.


5.7 Mechanism of Action

Fluticasone propionate works through an unknown mechanism to affect the action of various cell types and mediators of inflammation. Fluticasone propionate activates glucocorticoid receptors and inhibits lung eosinophilia in rats.


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - OINTMENT;TOPICAL - 0.005% **Federal ...DOSAGE - OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19957

read-more

DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY ...DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20121

read-more

DOSAGE - SPRAY, METERED;NASAL - 0.137MG/SPRAY...DOSAGE - SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

USFDA APPLICATION NUMBER - 202236

read-more

DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY

USFDA APPLICATION NUMBER - 205434

read-more

DOSAGE - POWDER;INHALATION - 0.05MG/INH

USFDA APPLICATION NUMBER - 20833

read-more

DOSAGE - POWDER;INHALATION - 0.1MG/INH

USFDA APPLICATION NUMBER - 20833

read-more

DOSAGE - POWDER;INHALATION - 0.25MG/INH

USFDA APPLICATION NUMBER - 20833

read-more

DOSAGE - POWDER;INHALATION - 0.03MG/INH

USFDA APPLICATION NUMBER - 208798

read-more

DOSAGE - POWDER;INHALATION - 0.055MG/INH

USFDA APPLICATION NUMBER - 208798

read-more

DOSAGE - POWDER;INHALATION - 0.113MG/INH

USFDA APPLICATION NUMBER - 208798

read-more

DOSAGE - POWDER;INHALATION - 0.232MG/INH

USFDA APPLICATION NUMBER - 208798

read-more

DOSAGE - POWDER;INHALATION - 0.055MG/INH;EQ 0...DOSAGE - POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH

USFDA APPLICATION NUMBER - 208799

read-more

DOSAGE - POWDER;INHALATION - 0.113MG/INH;EQ 0...DOSAGE - POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

USFDA APPLICATION NUMBER - 208799

read-more

DOSAGE - POWDER;INHALATION - 0.232MG/INH;EQ 0...DOSAGE - POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH

USFDA APPLICATION NUMBER - 208799

read-more

DOSAGE - POWDER;INHALATION - 0.1MG/INH;EQ 0.0...DOSAGE - POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH

USFDA APPLICATION NUMBER - 21077

read-more

DOSAGE - POWDER;INHALATION - 0.25MG/INH;EQ 0....DOSAGE - POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

USFDA APPLICATION NUMBER - 21077

read-more

DOSAGE - POWDER;INHALATION - 0.5MG/INH;EQ 0.0...DOSAGE - POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH

USFDA APPLICATION NUMBER - 21077

read-more

DOSAGE - LOTION;TOPICAL - 0.05% **Federal Reg...DOSAGE - LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21152

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.045M...DOSAGE - AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH

USFDA APPLICATION NUMBER - 21254

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.115M...DOSAGE - AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH

USFDA APPLICATION NUMBER - 21254

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.23MG...DOSAGE - AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

USFDA APPLICATION NUMBER - 21254

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.044M...DOSAGE - AEROSOL, METERED;INHALATION - 0.044MG/INH

USFDA APPLICATION NUMBER - 21433

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.11MG...DOSAGE - AEROSOL, METERED;INHALATION - 0.11MG/INH

USFDA APPLICATION NUMBER - 21433

read-more

DOSAGE - AEROSOL, METERED;INHALATION - 0.22MG...DOSAGE - AEROSOL, METERED;INHALATION - 0.22MG/INH

USFDA APPLICATION NUMBER - 21433

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 80474-14-2 / Fluticasone Propionate API manufacturers, exporters & distributors?

Fluticasone Propionate manufacturers, exporters & distributors 1

97

PharmaCompass offers a list of Fluticasone Propionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluticasone Propionate manufacturer or Fluticasone Propionate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluticasone Propionate manufacturer or Fluticasone Propionate supplier.

PharmaCompass also assists you with knowing the Fluticasone Propionate API Price utilized in the formulation of products. Fluticasone Propionate API Price is not always fixed or binding as the Fluticasone Propionate Price is obtained through a variety of data sources. The Fluticasone Propionate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Fluticasone Propionate

Synonyms

80474-14-2, Flovent, Cutivate, Flixotide, Flonase, Flixonase

Cas Number

80474-14-2

Unique Ingredient Identifier (UNII)

O2GMZ0LF5W

About Fluticasone Propionate

A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.

Prestwick2_000997 Manufacturers

A Prestwick2_000997 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prestwick2_000997, including repackagers and relabelers. The FDA regulates Prestwick2_000997 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prestwick2_000997 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Prestwick2_000997 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Prestwick2_000997 Suppliers

A Prestwick2_000997 supplier is an individual or a company that provides Prestwick2_000997 active pharmaceutical ingredient (API) or Prestwick2_000997 finished formulations upon request. The Prestwick2_000997 suppliers may include Prestwick2_000997 API manufacturers, exporters, distributors and traders.

click here to find a list of Prestwick2_000997 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Prestwick2_000997 USDMF

A Prestwick2_000997 DMF (Drug Master File) is a document detailing the whole manufacturing process of Prestwick2_000997 active pharmaceutical ingredient (API) in detail. Different forms of Prestwick2_000997 DMFs exist exist since differing nations have different regulations, such as Prestwick2_000997 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Prestwick2_000997 DMF submitted to regulatory agencies in the US is known as a USDMF. Prestwick2_000997 USDMF includes data on Prestwick2_000997's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prestwick2_000997 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Prestwick2_000997 suppliers with USDMF on PharmaCompass.

Prestwick2_000997 JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Prestwick2_000997 Drug Master File in Japan (Prestwick2_000997 JDMF) empowers Prestwick2_000997 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Prestwick2_000997 JDMF during the approval evaluation for pharmaceutical products. At the time of Prestwick2_000997 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Prestwick2_000997 suppliers with JDMF on PharmaCompass.

Prestwick2_000997 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Prestwick2_000997 Drug Master File in Korea (Prestwick2_000997 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prestwick2_000997. The MFDS reviews the Prestwick2_000997 KDMF as part of the drug registration process and uses the information provided in the Prestwick2_000997 KDMF to evaluate the safety and efficacy of the drug.

After submitting a Prestwick2_000997 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prestwick2_000997 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Prestwick2_000997 suppliers with KDMF on PharmaCompass.

Prestwick2_000997 CEP

A Prestwick2_000997 CEP of the European Pharmacopoeia monograph is often referred to as a Prestwick2_000997 Certificate of Suitability (COS). The purpose of a Prestwick2_000997 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prestwick2_000997 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prestwick2_000997 to their clients by showing that a Prestwick2_000997 CEP has been issued for it. The manufacturer submits a Prestwick2_000997 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prestwick2_000997 CEP holder for the record. Additionally, the data presented in the Prestwick2_000997 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prestwick2_000997 DMF.

A Prestwick2_000997 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prestwick2_000997 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Prestwick2_000997 suppliers with CEP (COS) on PharmaCompass.

Prestwick2_000997 WC

A Prestwick2_000997 written confirmation (Prestwick2_000997 WC) is an official document issued by a regulatory agency to a Prestwick2_000997 manufacturer, verifying that the manufacturing facility of a Prestwick2_000997 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prestwick2_000997 APIs or Prestwick2_000997 finished pharmaceutical products to another nation, regulatory agencies frequently require a Prestwick2_000997 WC (written confirmation) as part of the regulatory process.

click here to find a list of Prestwick2_000997 suppliers with Written Confirmation (WC) on PharmaCompass.

Prestwick2_000997 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prestwick2_000997 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Prestwick2_000997 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Prestwick2_000997 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Prestwick2_000997 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prestwick2_000997 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Prestwick2_000997 suppliers with NDC on PharmaCompass.

Prestwick2_000997 GMP

Prestwick2_000997 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Prestwick2_000997 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prestwick2_000997 GMP manufacturer or Prestwick2_000997 GMP API supplier for your needs.

Prestwick2_000997 CoA

A Prestwick2_000997 CoA (Certificate of Analysis) is a formal document that attests to Prestwick2_000997's compliance with Prestwick2_000997 specifications and serves as a tool for batch-level quality control.

Prestwick2_000997 CoA mostly includes findings from lab analyses of a specific batch. For each Prestwick2_000997 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Prestwick2_000997 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prestwick2_000997 EP), Prestwick2_000997 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prestwick2_000997 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty